In this letter, a case is described where an anesthesia machine, which is equipped with an optional available auxiliary common gas outlet (ACGO), is used. In the described specific case, anesthesia has been provided initially by using a T-piece breathing system which was connected to this ACGO. Later on, the anesthesia provider decided to switch to automatic ventilation with the standard circle system. The steps to switch over from ACGO mode to automatic ventilation mode are described in the Instructions for Use of the Fabius Tiro. 2 However, in this case, the anesthesia providers did not follow the Instructions for Use completely, with the result that the anesthesia machine did not correctly ventilate the patient. In order to better explain what happened, we would like to describe the functional principle of this specific anesthesia machine:
When the machine is switched to ACGO mode, the fresh gas, enriched with the anesthesia agent from the vapor, is directly guided from the ACGO outlet of the Ventilator through the T-piece breathing system and connected to the patient.
Switching the machine to automatic ventilation is a two-step approach and is described in the Instructions for Use of the Fabius Tiro. 2 In this specific case described by Dr Shah, the anesthesia provider did not switch the anesthesia machine completely to automatic ventilation as described in the Instructions for Use. 1 The fresh gas was still delivered to the ACGO outlet of the machine while the patient was connected to the circle system. Therefore no fresh gas was delivered to the patient.
In such a situation, the patient is ventilated with room air. This is part of the safety system of the Fabius anesthesia machine; the device is designed to continue ventilation even in the case of fresh gas problems (ie, problems with central gas supply or cylinder is empty). In order to alert the user of such a situation, the anesthesia machine will alarm with the insp O2 low alarm (high priority alarm). The anesthesia provider has to set patient-specific alarm limits to get this alarm at the right time. Furthermore, additional low MAC and low agent alarms from the mandatory CO2 and agent monitoring would further alert the user of the incorrect set up.
By investigating this specific case described by Dr Shah et. al., we did not find any details how FiO2 measurement had been connected to the T-piece breathing system nor how CO2 or volatile agent concentration have been measured. In their letter, they described the low FiO2
Alarm factory limit as 18%. This is not correct: factory standard of the In the section on hybrid therapy in patients with hypoplastic left heart syndrome (HLHS), however, it should be pointed out that this procedure is carried out very differently throughout the world. In many centers, in addition to surgical bilateral banding of the pulmonary arteries (bPAB), a reverse Blalock-Taussig shunt is used or the ductus arteriosus (DA) is transpulmonary stented during the same procedure. In addition to patients' risk factors, often more prevalent in the hybrid patients, 2,3 this could be the reason for the poorer results in some centers compared to Norwood stage I with right ventricle to pulmonary artery shunt.
In many patients, the DA stenting can be performed as a separate procedure after surgical bPAB using a transfemoral access. Until then the prostaglandin E2 infusion will be continued (Giessen hybrid stage I approach). This minimal handling approach is associated with an operative hybrid stage I mortality of 2.5% 4 and an overall 15 year survival rate of 78% in specialized centers. A birth weight <2.5 kg has no negative influence on the outcome using this approach. 5
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